Allergy News and Research

RSS

The term allergy encompasses a wide range of conditions; it is not a disease in itself. In 1906 Clemens von Pirquet was the first to describe allergies as a changed or altered reaction of the immune system in response to exposure to foreign proteins. These days the term allergy – medically termed hypersensitivity, signifies an exaggerated reaction to foreign substances.

Innovative study on asthma inflammation funded by NIH/NIAID grant

In a significant stride for respiratory medicine, Lundquist Institute (TLI) investigator Nicholas Jendzjowsky, PhD, has been awarded a prestigious grant from the National Institute of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID).

21 Mar 2024

Immune cell protein identified as potential target for rare liver cancer treatment

Fibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed early with surgery. The disease is caused by a single genetic mutation that creates a fusion protein.

20 Mar 2024

Needle pain is a big problem for kids. One California doctor has a plan.

Almost all new parents go through it: the distress of hearing their child scream at the doctor's office.

20 Mar 2024

Milk ladder approach offers hope for children with cow's milk allergy

Researchers review milk ladder use for managing cow's milk allergy in children, emphasizing its potential in safely introducing cow's milk to induce tolerance and the need for standardization and further research.

19 Mar 2024

New drug candidates show promise to reverse HIV immune evasion

University of Pittsburgh School of Medicine scientists have identified drug candidates that show promise to reverse the ability of HIV to escape detection by the immune system.

19 Mar 2024

Study uncovers how APOBEC enzymes drive cancer mutations

A research team led by the University of California, Irvine has discovered the key role that the APOBEC3A and APOBEC3B enzymes play in driving cancer mutations by modifying the DNA in tumor genomes, offering potential new targets for intervention strategies.

18 Mar 2024

Study shows the economic benefits of reducing socioeconomic disparities in youth physical activity

What would happen if the existing disparities in physical activity levels between youth of lower and higher socioeconomic statuses were eliminated?

15 Mar 2024

Researchers find link between gut bacteria and the success of milk-allergy oral immunotherapy

Researchers led by Hiroshi Ohno at the RIKEN Center for Integrative Medical Sciences in Japan have discovered a link between gut bacteria and the success of milk-allergy oral immunotherapy.

14 Mar 2024

AI technologies can accurately identify cases of healthcare-associated infections

A new proof-of-concept study published today in the American Journal of Infection Control (AJIC) reports that artificial intelligence (AI) technologies can accurately identify cases of healthcare-associated infections (HAI) even in complex clinical scenarios.

14 Mar 2024

World Vaccine Congress draws leaders from government, science and industry

Sessions cover topics from cancer vaccines to logistics and the next.

From World Vaccine Congress Washington 13 Mar 2024

NIH study uncovers vulnerable sites on Epstein-Barr virus protein

Studies of interactions between two lab-generated monoclonal antibodies (mAbs) and an essential Epstein-Barr virus (EBV) protein have uncovered targets that could be exploited in designing treatments and vaccines for this extremely common virus.

12 Mar 2024

Vaginal ring and oral PrEP found to be safe for HIV prevention among pregnant cisgender women

The monthly dapivirine vaginal ring and daily oral pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate and emtricitabine were each found to be safe for HIV prevention among cisgender women who started using one of them in their second trimester of pregnancy, according to findings presented today at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI) in Denver.

5 Mar 2024

Study shows semaglutide as a safe and effective therapy for MASLD in people with HIV

A weekly injection of semaglutide was safe and reduced the amount of fat in the liver by 31% in people with HIV and metabolic dysfunction-associated steatotic liver disease (MASLD), according to a presentation today at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI) in Denver.

5 Mar 2024

Newly identified antibodies target a hard-to-spot region of the influenza virus

Researchers at the National Institutes of Health have identified antibodies targeting a hard-to-spot region of the influenza virus, shedding light on the relatively unexplored "dark side" of the neuraminidase (NA) protein head.

1 Mar 2024

'Pandemic babies' show altered gut microbiome development and lower allergy rates, study finds

Lockdowns imposed during the COVID-19 pandemic had an impact on the gut microbiome development of babies born during these periods according to new research from RCSI University of Medicine and Health Sciences, Children's Health Ireland and APC Microbiome Ireland (APC), a world leading SFI Research Centre, based in University College Cork.

29 Feb 2024

Allergy News and Research

Further Reading

Innovative study on asthma inflammation funded by NIH/NIAID grant

Immune cell protein identified as potential target for rare liver cancer treatment

Needle pain is a big problem for kids. One California doctor has a plan.

Milk ladder approach offers hope for children with cow's milk allergy

New drug candidates show promise to reverse HIV immune evasion

Study uncovers how APOBEC enzymes drive cancer mutations

Study shows the economic benefits of reducing socioeconomic disparities in youth physical activity

Researchers find link between gut bacteria and the success of milk-allergy oral immunotherapy

AI technologies can accurately identify cases of healthcare-associated infections

World Vaccine Congress draws leaders from government, science and industry

NIH study uncovers vulnerable sites on Epstein-Barr virus protein

Vaginal ring and oral PrEP found to be safe for HIV prevention among pregnant cisgender women

Study shows semaglutide as a safe and effective therapy for MASLD in people with HIV

Newly identified antibodies target a hard-to-spot region of the influenza virus

'Pandemic babies' show altered gut microbiome development and lower allergy rates, study finds

Study reveals a safe path to overcoming food allergies for older children

New blood biomarkers identified to predict cardiovascular risk in rheumatoid arthritis patients

Omalizumab boosts tolerance to multiple food allergies, study finds

New clinical practice guideline offers evidence-based recommendations for managing inhalant allergies with immunotherapy

Omalizumab shows promise in preventing food allergy reactions in children, study finds

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News